Impaired Innate Immunity in Mice but Preserved CD8 T Cell Responses against in -, -, - or -Deficient Mice

English version České info

The murine model of T. cruzi infection has provided compelling evidence that development of host resistance against intracellular protozoans critically depends on the activation of members of the Toll-like receptor (TLR) family via the MyD88 adaptor molecule. However, the possibility that TLR/MyD88 signaling pathways also control the induction of immunoprotective CD8⁺ T cell-mediated effector functions has not been investigated to date. We addressed this question by measuring the frequencies of IFN-γ secreting CD8⁺ T cells specific for H-2K^b-restricted immunodominant peptides as well as the in vivo Ag-specific cytotoxic response in infected animals that are deficient either in TLR2, TLR4, TLR9 or MyD88 signaling pathways. Strikingly, we found that T. cruzi-infected Tlr2^−/−, Tlr4^−/−, Tlr9^−/⁻ or Myd88^−/− mice generated both specific cytotoxic responses and IFN-γ secreting CD8⁺ T cells at levels comparable to WT mice, although the frequency of IFN-γ⁺CD4⁺ cells was diminished in infected Myd88^−/− mice. We also analyzed the efficiency of TLR4-driven immune responses against T. cruzi using TLR4-deficient mice on the C57BL genetic background (B6 and B10). Our studies demonstrated that TLR4 signaling is required for optimal production of IFN-γ, TNF-α and nitric oxide (NO) in the spleen of infected animals and, as a consequence, Tlr4^−/− mice display higher parasitemia levels. Collectively, our results indicate that TLR4, as well as previously shown for TLR2, TLR9 and MyD88, contributes to the innate immune response and, consequently, resistance in the acute phase of infection, although each of these pathways is not individually essential for the generation of class I-restricted responses against T. cruzi.

Vyšlo v časopise: Impaired Innate Immunity in Mice but Preserved CD8 T Cell Responses against in -, -, - or -Deficient Mice. PLoS Pathog 6(4): e32767. doi:10.1371/journal.ppat.1000870
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000870

Souhrn

Zdroje

1. DutraWO

GollobKJ

2008 Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 21 287 292

2. IwasakiA

MedzhitovR

2004 Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 987 995

3. CamposMA

AlmeidaIC

TakeuchiO

AkiraS

ValenteEP

2001 Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 167 416 423

4. OuaissiA

GuilvardE

DelnesteY

CaronG

MagistrelliG

2002 The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J Immunol 168 6366 6374

5. OliveiraA-C

PeixotoRJ

ArrudaLB

CamposMA

GazzinelliRT

2004 Expression of functional TLR4 confers pro-inflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol 173 5688 5696

6. BaficaA

SantiagoHC

GoldszmidR

RopertC

GazzinelliRT

2006 Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 177 3515 3519

7. CamposMA

CloselM

ValenteEP

CardosoJE

AkiraS

2004 Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J Immunol 172 1711 1718

8. KogaR

HamanoS

KuwataH

AtarashiK

OgawaM

2006 TLR-dependent induction of IFN-β mediates host defense against Trypanosoma cruzi. J Immunol 177 7059 7066

9. PoltorakA

HeX

SmirnovaI

LiuMY

Van HuffelC

1998 Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 2085 2088

10. TakeuchiO

HoshinoK

KawaiT

SanjoH

TakadaH

1999 Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11 443 451

11. LatzE

VisintinA

LienE

FitzgeraldKA

MonksBG

2002 Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277 47834 47843

12. TanakaY

KiyotakiC

TanowitzH

BloomBR

1982 Reconstitution of a variant macrophage cell line defective in oxygen metabolism with a H2O2-generating system. Proc Natl Acad Sci U S A 79 2584 2588

13. LocksleyRM

KlebanoffSJ

1983 Oxygen-dependent microbicidal systems of phagocytes and host defense against intracellular protozoa. J Cell Biochem 22 173 185

14. Munoz-FernandezMA

FernandezMA

FresnoM

1992 Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 22 301 307

15. VespaGN

CunhaFQ

SilvaJS

1994 Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 62 5177 5182

16. BalcerczykA

SowaK

BartoszG

2007 Metal chelators react also with reactive oxygen and nitrogen species. Biochem Biophys Res Commun 352 522 525

17. MartinsGA

VieiraLQ

CunhaFQ

SilvaJS

1999 Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun 67 3864 3871

18. GazzinelliRT

OswaldIP

HienyS

JamesSL

SherA

1992 The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22 2501 2506

19. MartinD

TarletonR

2004 Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol Rev 201 304 317

20. LowHP

SantosMA

WizelB

TarletonRL

1998 Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. J Immunol 160 1817 1823

21. MartinDL

WeatherlyDB

LaucellaSA

CabinianMA

CrimMT

2006 CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2 e77 doi:10.1371/journal.ppat.0020077

22. TzelepisF

de AlencarBC

PenidoML

GazzinelliRT

PersechiniPM

2006 Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect Immun 74 2477 2481

23. MedeirosMM

PeixotoJR

OliveiraAC

Cardilo-ReisL

KoatzVL

2007 Toll-like receptor 4 (TLR4)-dependent proinflammatory and immunomodulatory properties of the glycoinositolphospholipid (GIPL) from Trypanosoma cruzi. J Leukoc Biol 82 488 496

24. TardieuxI

WebsterP

RaveslootJ

BoronW

LunnJA

1992 Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 71 1117 1130

25. BurleighBA

2005 Host cell signaling and Trypanosoma cruzi invasion: do all roads lead to lysosomes? Sci STKE 2005 pe36

26. WoolseyAM

SunwooL

PetersenCA

BrachmannSM

CantleyLC

2003 Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J Cell Sci 116 3611 3622

27. UnderhillDM

GantnerB

2004 Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect 6 1368 1373

28. Maganto-GarciaE

PunzonC

TerhorstC

FresnoM

2008 Rab5 activation by Toll-like receptor 2 is required for Trypanosoma cruzi internalization and replication in macrophages. Traffic 9 1299 1315

29. BlanderJM

MedzhitovR

2004 Regulation of phagosome maturation by signals from toll-like receptors. Science 304 1014 1018

30. DenicolaA

RubboH

RodriguezD

RadiR

1993 Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys 304 279 286

31. AlvarezMN

PiacenzaL

IrigoinF

PeluffoG

RadiR

2004 Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi. Arch Biochem Biophys 432 222 232

32. HolscherC

KohlerG

MullerU

MossmannH

SchaubGA

1998 Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66 1208 1215

33. SaeftelM

FleischerB

HoeraufA

2001 Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 69 2252 2259

34. WrightsmanR

KrassnerS

WatsonJ

1982 Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Infect Immun 36 637 644

35. TrischmannTM

BloomBR

1982 Genetics of murine resistance to Trypanosoma cruzi. Infect Immun 35 546 551

36. AlibertiJC

SoutoJT

MarinoAP

Lannes-VieiraJ

TeixeiraMM

2001 Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158 1433 1440

37. KayamaH

KogaR

AtarashiK

OkuyamaM

KimuraT

2009 NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection. PLoS Pathog 5 e1000514 doi:10.1371/journal.ppat.1000514

38. MachadoAV

CardosoJE

ClaserC

RodriguesMM

GazzinelliRT

2006 Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 17 898 908

39. TzelepisF

PersechiniPM

RodriguesMM

2007 Modulation of CD4+ T cell-dependent specific cytotoxic CD8+ T cells differentiation and proliferation by the timing of increase in the pathogen load. PLoS ONE 2 e393 doi:10.1371/journal.pone.0000393

40. SilvaGK

GutierrezFRS

GuedesPMM

HortaCV

CunhaLD

2009 Cutting Edge: Nucleotide-Binding Oligomerization Domain 1-Dependent Responses Account for Murine Resistance against Trypanosoma cruzi Infection. J Immunol jimmunol.0902254

41. MonteiroAC

SchmitzV

MorrotA

de ArrudaLB

NagajyothiF

2007 Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog 3 e185 doi:10.1371/journal.ppat.0030185

42. GallucciS

LolkemaM

MatzingerP

1999 Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5 1249 1255

43. LuftT

PangKC

ThomasE

HertzogP

HartDN

1998 Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161 1947 1953

44. CurtsingerJM

ValenzuelaJO

AgarwalP

LinsD

MescherMF

2005 Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 174 4465 4469

45. LangPA

Cervantes-BarraganL

VerschoorA

NavariniAA

RecherM

2009 Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood 113 1045 1052

46. CostaVM

TorresKC

MendoncaRZ

GresserI

GollobKJ

2006 Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J Immunol 177 3193 3200

47. EganCE

SukhumavasiW

ButcherBA

DenkersEY

2009 Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii. Clin Exp Immunol 156 17 24

48. SukhumavasiW

EganCE

WarrenAL

TaylorGA

FoxBA

2008 TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J Immunol 181 3464 3473

49. BolzDD

SundsbakRS

MaY

AkiraS

KirschningCJ

2004 MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 173 2003 2010

50. von BernuthH

PicardC

JinZ

PanklaR

XiaoH

2008 Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321 691 696

51. WaySS

KollmannTR

HajjarAM

WilsonCB

2003 Cutting edge: protective cell-mediated immunity to Listeria monocytogenes in the absence of myeloid differentiation factor 88. J Immunol 171 533 537

52. ShiS

NathanC

SchnappingerD

DrenkowJ

FuortesM

2003 MyD88 Primes Macrophages for Full-Scale Activation by Interferon-{gamma} yet Mediates Few Responses to Mycobacterium tuberculosis. J Exp Med 198 987 997

53. TarletonRL

GrusbyMJ

PostanM

GlimcherLH

1996 Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol 8 13 22

54. KumarS

TarletonRL

1998 The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 20 207 216

55. PasareC

MedzhitovR

2005 Control of B-cell responses by Toll-like receptors. Nature 438 364 368

56. GavinAL

HoebeK

DuongB

OtaT

MartinC

2006 Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314 1936 1938

57. BrowneEP

LittmanDR

2009 Myd88 is required for an antibody response to retroviral infection. PLoS Pathog 5 e1000298 doi:10.1371/journal.ppat.1000870

58. HeerAK

ShamshievA

DondaA

UematsuS

AkiraS

2007 TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol 178 2182 2191

59. GuayHM

AndreyevaTA

GarceaRL

WelshRM

Szomolanyi-TsudaE

2007 MyD88 is required for the formation of long-term humoral immunity to virus infection. J Immunol 178 5124 5131

60. NakanishiY

LuB

GerardC

IwasakiA

2009 CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help. Nature 462 510 513

61. Pereira da SilvaLH

NussenzweigV

1953 Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Fol Clin Biol 20 191

62. GreenLC

WagnerDA

GlogowskiJ

SkipperPL

WishnokJS

1982 Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126 131 138

63. de AlencarBC

AraujoAF

PenidoML

GazzinelliRT

RodriguesMM

2007 Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells. Vaccine 25 6018 6027

64. MartinDL

TarletonRL

2005 Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent Trypanosoma cruzi Infection. J Immunol 174 1594 1601